... for the Phase 1 dose-escalation portion of the ongoing Phase 1/2 clinical trial of OP-1250 at the San Antonio Breast Cancer Symposium (SABCS).
News
- Olema Oncology Issues Statement Regarding Falsified Information Circulating on Social Media
- City officials respond to "Ousted" report on code enforcement-related displacements in San Antonio
According to a recent report from the University of Texas School of Law, the City of San Antonio used code enforcement violations to issue orders ...
- Tulane to be main tenant in former Charity Hospital - mySA
'Rarely seen' species spotted using San Antonio land bridge ... transform New Orleans into a hub of bioscience research,” the news release said.
- Gilead's Bold Ambition of Transforming Triple-Negative Breast Cancer Treatment to Be ...
(Nasdaq: GILD) will present additional data from the Phase 3 ASCENT study of Trodelvy ® (sacituzumab govitecan-hziy) during the upcoming San Antonio ...
- Jack Dorsey to Step Down as CEO of Twitter: 'It's Finally Time for Me to Leave' - Editorials24.com
That Bigfoot Show covers a 2009 Bigfoot sighting in San Antonio ... A Senior writer & Editor, James is a postgraduate in biotechnology and has an ...